Preoperative evaluation of pelvic masses with combined 18F‐fluorodeoxyglucose positron emission tomography and computed tomography

No abstract is available for this paper.

• Publication year

  2008

• Venue

  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

• Publication date

  2008-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijgo.2008.02.019PMID 18423470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Positron emission tomography and leiomyomas: clinicopathologic analysis of 3 cases of PET scan-positive leiomyomas and literature review.

  2007cited by this paper
• Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histology

  2007cited by this paper
• The diagnostic value of PET/CT for primary ovarian cancer--a prospective study.

  2007cited by this paper
• The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study.

  2007cited by this paper
• Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis of ovarian carcinoma.

  2007cited by this paper
• Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.

  2007cited by this paper
• Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma

  2006cited by this paper
• The impact of PET/CT in the management of recurrent ovarian cancer.

  2006cited by this paper
• PET imaging in gynecologic malignancies.

  2004cited by this paper
• Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer.

  2004cited by this paper
• Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.

  2004cited by this paper
• Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings.

  2001cited by this paper
• Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography.

  2000cited by this paper
• Borderline ovarian malignancy: ultrasound and fast dynamic MR findings.

  1998cited by this paper
• The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma.

  1994cited by this paper
• Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG).

  1993cited by this paper
• The impact of subspecialty training on the management of advanced ovarian cancer.

  1992cited by this paper
• Borderline epithelial ovarian tumors: a review of 81 cases with an assessment of the impact of treatment.

  1992cited by this paper
• Medical audit, cancer registration, and survival in ovarian cancer.

  1991cited by this paper
• A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer

  1991cited by this paper
• Serous ovarian tumors of low malignant potential with peritoneal implants

  1990cited by this paper
• Epithelial ovarian tumors of borderline malignancy.

  1990cited by this paper
• Serum CA 125 Levels in Preoperative Evaluation of Pelvic Masses

  1988cited by this paper
• Comparison of Serum CA 125, Clinical Impression, and Ultrasound in the Preoperative Evaluation of Ovarian Masses

  1988cited by this paper

• Impact of lymph node staging on survival in presumed early-stage ovarian cancer: a multicentric retrospective study.

  2025cites this paper
• Tomographie par émission de positons au 18fluorodéoxyglucose et cancers gynécologiques pelviens

  2025cites this paper
• Diagnostic accuracy and clinical value of [68Ga]Ga-FAPI-46 PET/CT for staging patients with ovarian cancer: study protocol for a prospective clinical trial

  2024cites this paper
• Alteration of glucose metabolism and expression of glucose transporters in ovarian cancer

  2024cites this paper
• ACR Appropriateness Criteria® Clinically Suspected Adnexal Mass, No Acute Symptoms: 2023 Update.

  2024cites this paper
• Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers

  2023cites this paper
• 18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature

  2023influential citation
• The Diagnostic Performance of Maximum Uptake Value and Apparent Diffusion Coefficient in Differentiating Benign and Malignant Ovarian or Adnexal Masses: A Meta-Analysis

  2022cites this paper
• Characteristics Patients with Borderline Ovarian Tumor at Sanglah General Hospital: From Pre- to Post-operative Approach

  2022cites this paper
• ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors

  2021cites this paper
• ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumours

  2021influential citation
• Consensus Statement on preoperative diagnosis of ovarian tumors

  2021cites this paper
• Primary peritoneal serous carcinoma: a primer for radiologists.

  2021cites this paper
• Indirect comparison of the diagnostic performance of 18F-FDG PET/CT and MRI in differentiating benign and malignant ovarian or adnexal tumors: a systematic review and meta-analysis

  2021cites this paper
• The role of CT, PET-CT, and MRI in ovarian cancer.

  2021cites this paper
• A Comparative Study between 18F-FDG PET/CT and Conventional Imaging in the Evaluation of Progressive Disease and Recurrence in Ovarian Carcinoma

  2021cites this paper
• The diagnostic performance of 18F-FDG PET/CT and MRI in differentiating benign and malignant ovarian tumors: an indirect comparative analysis

  2021cites this paper
• Carcinoma of the Ovaries and Fallopian Tubes

  2020cites this paper
• 18F-FDG-PET/CT in Breast and Gynecologic Cancer

  2020cites this paper
• Diagnostic performance of PET/CT and PET/MR in the management of ovarian carcinoma—a literature review

  2020cites this paper
• [Borderline ovarian tumours: CNGOF Guidelines for clinical practice -Imaging].

  2020cites this paper
• The role of 18F-FDG PET/CT imaging in the diagnosis of ovarian cancer

  2019cites this paper
• PET/CT for Evaluation of Ovarian Cancer.

  2019cites this paper
• The role of 18F-FDG PET/CT imaging in the diagnosis of ovarian cancer.

  2019cites this paper
• Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy

  2018cites this paper
• The value of combining 18 F-FDG PET / CT and contrast-enhanced MR in the evaluation of ovarian masses with solid component or thickened septa

  2018cites this paper
• The Prognostic Value of 18F-FDG PET/CT in Monitoring Chemotherapy in Ovarian Cancer Both at Initial Diagnosis and at Recurrent Disease.

  2018cites this paper
• Fludeoxyglucose F 18 PET/CT Assessment of Ovarian Cancer.

  2018cites this paper
• Transrectal or transvaginal ultrasoundguided biopsy for pelvic masses: external validation and usefulness in oncologic patients

  2018cites this paper
• An update on the role of PET/CT and PET/MRI in ovarian cancer

  2017cites this paper
• Low uptake of fluorodeoxyglucose in positron emission tomography/computed tomography in ovarian clear cell carcinoma may reflect glutaminolysis of its cancer stem cell-like properties.

  2017cites this paper
• Calcium Signaling in Interstitial Cells: Focus on Telocytes

  2017cites this paper
• Positron Emission Tomography/Computed Tomography for Gynecologic Malignancies

  2016cites this paper
• Diagnostic Applications of Nuclear Medicine: Ovarian Cancer

  2016cites this paper
• FDG-PET/CT to Predict Optimal Primary Cytoreductive Surgery in Patients with Advanced Ovarian Cancer: Preliminary Results

  2016cites this paper
• Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

  2016cites this paper
• Detection of asymptomatic enthesitis in psoriasis patients: An onset of psoriatic arthritis?

  2016cites this paper
• Fertility sparing treatment in borderline ovarian tumours

  2015cites this paper
• Adult granulosa cell tumor presenting with massive ascites, elevated CA-125 level, and low 18F-fluorodeoxyglucose uptake on positron emission tomography/computed tomography

  2015cites this paper
• Advanced epithelial ovarian cancer – studies on preoperative [18F] FDG PET/CT and HE4 profile during primary chemotherapy

  2015cites this paper
• Imaging techniques for the pre-surgical diagnosis of adnexal tumours.

  2014cites this paper
• Assessment of Combination of Contrast-Enhanced Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography for Evaluation of Ovarian Masses

  2014cites this paper
• Bioenergetic Analysis of Ovarian Cancer Cell Lines: Profiling of Histological Subtypes and Identification of a Mitochondria-Defective Cell Line

  2014cites this paper
• Management of epithelial ovarian cancer from diagnosis to restaging: an overview of the role of imaging techniques with particular regard to the contribution of 18F-FDG PET/CT

  2014cites this paper
• Diagnostic Value of Preoperative SUVmax on FDG-PET/CT for the Detection of Ovarian Cancer

  2014cites this paper
• The special role of ultrasound for screening, staging and surveillance of malignant ovarian tumors: distinction from other methods of diagnostic imaging

  2014cites this paper
• 18F‐Fluorodeoxyglucose uptake and clinicopathological features of recurrent or metastatic endometrial stromal sarcoma

  2014cites this paper
• Assessment of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in the preoperative management of patients with gastric cancer

  2014cites this paper
• Imaging techniques for the evaluation of ovarian cancer.

  2014cites this paper
• PET-CT of Gynecological Malignancies and Ovarian Cancer

  2014cites this paper
• Best Practice & Research Clinical Obstetrics and Gynaecology

  2014cites this paper
• NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines

  2014cites this paper
• PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer.

  2013cites this paper
• [Positron emission tomography (PET) in malignant ovarian tumors].

  2013cites this paper
• Borderline Tumor (Serous/Mucinous/ Endometrioid) (Clinical Setting and US)

  2013cites this paper
• Altchek's Diagnosis and Management of Ovarian Disorders: Ultrasound, MRI, CT, and PET imaging of ovarian cancer

  2013cites this paper
• Borderline Epithelial Tumors of the Ovary

  2013cites this paper
• PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis.

  2012cites this paper
• The preoperative diagnosis of borderline ovarian tumors: a review of current literature

  2012cites this paper
• Positron Emission Tomography/Computed Tomography Predictors of Overall Survival in Stage IIIC/IV Ovarian Cancer

  2012cites this paper
• Impact of FDG-PET and -PET/CT Imaging in the Clinical Decision-Making of Ovarian Carcinoma: An Evidence-Based Approach

  2012cites this paper
• Use of Positron Emission Tomography Imaging in Gynecologic Cancers

  2011cites this paper
• A new dimension of FDG-PET interpretation: assessment of tumor biology

  2011influential citation
• Early diagnosis of ovarian carcinoma: is a solution in sight?

  2011cites this paper
• Noninvasive and Invasive Staging of Ovarian Cancer: Review of the Literature

  2011cites this paper
• FDG-PET/CT for diagnosis of primary ovarian cancer

  2011cites this paper
• Spectrum of fluorodeoxyglucose-positron emission tomography/computed tomography and magnetic resonance imaging findings of ovarian tumors

  2011cites this paper
• Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI.

  2010cites this paper
• Best Practice & Research, Clinical Obstetrics & Gynaecology

  2010cites this paper
• Adnexal masses: US characterization and reporting.

  2010cites this paper
• Limits of 18F-Fluorodeoxyglucose Positron Emission Tomography in Recurrence Diagnosis of Borderline Ovarian Tumor

  2010cites this paper
• Positron emission tomography/computed tomography: a clinical tool for evaluation of enthesitis in patients with spondyloarthritides.

  2010cites this paper
• Role of PET in gynecologic malignancy

  2009cites this paper
• Molecular and clinical aspects of borderline ovarian tumours

  2009cites this paper
• Comparison of CT or MRI and 18F-FDG PET/CT for the Preoperative Staging Accuracy of Ovarian Cancer

  2009cites this paper
• Ovarian cancer: detection and radiologic staging.

  2009cites this paper
• Positron Emissie Tomografie

  2009cites this paper
• Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16α-18F-fluoro-17β-estradiol PET

  2009cites this paper
• Ovarian Cancer: Detection and Radiologic Staging

  2009cites this paper
• La tomographie par émission de positrons en Belgique

  2009cites this paper
• 腹部・骨盤部領域におけるF-18 FDG PET/CT検査の意義－パート３－

  2009cites this paper
• 腹部・骨盤部領域におけるF-18 FDG PET/CT検査の意義－パート２－

  2008cites this paper
• Appropriateness.

  2007cites this paper